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Bibliometric review of Classification of Alzheimer’s
Disease
ABSTRACT
Alzheimer's Disease (AD) is said to be the most prevailing Neurogenerative Disease. The
neurogenerative disease is stated in a gathering of disorders that affect the brain. Deep
Learning, the avant-garde machine learning approach is well prominent and this approach has
shown wonderful performance compared to traditional machine learning techniques to
identify convoluted structures in complicated high dimensionality data especially within the
realm of computer vision. The application of the Deep learning approach is to have an early
observation and mechanized classification of Alzheimer's Disease. Nowadays, it has gained a
great amount of recognition as neuro-imaging techniques have generated an extensive range
of multimodal neuro-imaging data. Deep learning Techniques and neuro-imaging data for
diagnostic classification of Alzheimer's Disease was carried out and has been scientifically
reviewed by a publication. Scopus and Google Scholar hunt was used to find some useful
papers on deep learning techniques for AD. These papers were judged, assessed, and
classified with the algorithms and neuro-imaging techniques and then the discovery was
summarized. The objective of this project is to discover the early symptoms of the disease
which are varying from age to age while classifying different stages of it along the way and
enhance the prediction and accuracy to our extent.

1. INTRODUCTION
Alzheimer’s disease is further manageable if the symptoms of Mild Cognitive Impairment
(MCI) are in early stage. This disease is fundamentally associated with the fluctuations in
brain which causes the deficiency of brain structure including the failing of neurons. In
accordance with the Neurologists statements, there is no cure for this disorder. On the
contrary unearthing early symptoms can help in early diagnosis of the disease. There are
certain treatments which can put back the symptoms if they are looked after within the
premature phases of the disease. Hence, an early identification of AD may be a major aspect
for the patients affected by it. This disease is misperceived with standard ageing outcomes
and hence Electroencephalography (EEG) has been present and defined as a constructive

technique which will help to smoothen the progress of premature diagnosis while an efficient
reason is it's simple to practice.
EEG is employed to image brain activities and it registers the brain signal by means of
electrodes affixed to the scalp. In addition to this, advanced neuroimaging techniques like
resonance Imaging (MRI) and Positron Emission Tomography (TMI) have also been
advanced and utilized within the diagnosis of AD. Deep learning methodologies like
Convolutional Neural Network (CNN) or Recurrent Neural Network (RNN) which uses
neuro-imaging data exclusive of extracting pre-processing for attribute selection have
produced a greater accuracy for AD classification. Analysis of AD applying structural MRI
and hybrid arrangement for creating a distinction among NC, MCI, and AD patients. EEG are
regularly exercised for positive correlation of brain functionalities, which may stand utilized
for monitoring brain motion, Non-linear analysis of EEG data displays the unique attributes
to discover the diagnosis of neurological disorders, like Alzheimer, Epilepsy, and
Parkinson’s. Numerous irregularities obtained in EEG signals of patients affected by AD
embrace decelerating of EEG signals, moderated complexity of EEG signals and
disconcertion in EEG synchrony.
1.1 HISTORICAL BACKGROUND
Alois Alzheimer, a German doctor, revealed the first instance of Alzheimer's disease in 1907.
He initially observed Auguste Deter, a 51-year-elderly person, in 1901. Auguste's spouse Karl
carried her to a psychological emergency clinic after she started displaying bizarre conduct,
including hiding items, undermining neighbors, and blaming her husband of adultery. She
additionally lost the capacity to do day by day exercises for example, cooking and
housework. Auguste went under Alzheimer's consideration at a psychological clinic in
Frankfurt. There he noticed and recorded her standards of conduct: she could talk yet not
keep in touch with her own name, she could name items, for example, a pencil yet not the
food she was eating, she was obliging occasionally however noisy and hostile at other times.
He determined Auguste to have "presenile dementia".
Upon her passing in 1906, Alzheimer's biopsy of her mind uncovered diffuse cortical decay
and "specific changes in cortical cell bunches". Alzheimer depicted plaques and tangles of
nerve filaments which scientists would distinguish in the 1980's as beta amyloid plaques and
neurofibrillary tangles of tau. That year, Alzheimer gave a presentation on Auguste at a
German psychiatry conference, asserting these cortical injuries to be the reason of her

indications. He distributed a research paper the following year, and a psychiatry textbook in
1910 named the problem 'Alzheimer's Disease.' The clinical symptomatic measures for AD
were normalized in the U.S. in 1984. They were updated in 2011 and 2018 to make separate
judgments for the preclinical, mild cognitive impairment (MCI) and dementia phases of AD
furthermore, to perceive the role of biomarkers in AD analysis.
1.2 PATHOGENESIS
AD is a perplexing, multifactorial, neurodegenerative infection, coming about because of
convoluted communications of one's hereditary makeup, education, age, and climate.
Numerous speculations have established the framework to pick up agreement of the etiology
of the infection, with one of the eldest being the cholinergic speculation. This theory depends
on the way that AD patients show decrease in action of choline acetyltransferase and
acetylcholinesterase in the cerebral cortex contrasted with the typical cerebrum. Postmortem
brain tissue from patients with AD affirmed the decreased neurotransmitter pathway activity,
uncovering

that

degeneration

of

cholinergic

neurons

and

loss

of

cholinergic

neurotransmission essentially contributes to the cognitive impairment found in those with
AD.
The Tau speculation has likewise been proposed, considering AD histopathology uncovers
intraneuronal neurofibrillary sores comprised of tau proteins. Tau proteins are essentially
found in neurons and are engaged with the assembly and stabilization of the neuronal
microtubule organization. Tau protein becomes obsessive when the phosphorylation
guideline gets unchecked and hyperphosphorylated tau proteins polymerize into fibers and
become neurofibrillary tangles. This prompts breakdown of the underlying and administrative
activities of the cytoskeleton and at that point prompts irregular morphology, axonal vehicle,
also, synaptic capacity of neurons, consequently prompting neurodegeneration.

Figure 1: The amyloid (Aβ) cascade hypothesis

These earlier speculations made ready to the broadly acknowledged hypothesis for the
pathogenesis of AD: the amyloid cascade hypothesis. This hypothesis credits clinical
sequelae of the sickness to the overproduction or diminished freedom of amyloid beta (Ab)
peptides, which at that point prompts expanded statement of Ab, besides, prompting neuronal
harm (Figure 1). The length of Ab shifts relying upon the posttranslational cleavage pattern
of the transmembrane amyloid forerunner protein (APP). Ab is produced by cleavage of APP
by means of one or the other b-or g-secretases, coming about in the scandalous insoluble Ab
fibrils. Two principal types of Ab polymers assume an immediate part in the pathology of
AD: Ab40 and Ab42. Ab40/Ab42 at that point oligomerizes, ventures to synaptic clefts, and
meddles with synaptic flagging. These in the end further polymerize into insoluble amyloid
fibrils that total into amyloid plaques. Inside the plaques, Ab peptides in b-sheet compliance
polymerize into basically unmistakable structures, including fibrillar, protofibers and
polymorphic oligomers. It is the deposition of these plaques diffusely all through the
cerebrum that lead to microglial enactment, cytokine discharge, reactive astrocytosis, and an
in general inflammatory reaction. These underlying changes lead to synaptic and neuronal
loss and inevitable gross cerebral decay. Then again, should APP be handled by a-secretase in
the solid grown-up, solvent b-amyloid is delivered, which has been connected to assume a
part in neuronal versatility/endurance, is defensive against excitotoxicity, is significant for

ahead of schedule CNS improvement, and has been demonstrated to be significant for
advancing neural connection development. The hereditary qualities of AD ought to likewise
be considered to assume a persuasive part in the pathogenesis, close by irritation, apoptosis,
and plaque development. The APP quality situated on 21q21, referenced above, was the
primary found causative quality of AD. Advances in hereditary research have recognized two
unmistakable types of AD: Familial Alzheimer's Disease (FAD) and Sporadic Alzheimer
Disease (SAD), with the last making up the dominant part of cases. Significant advances
during the 1990s and mid 2000s uncovered that FAD is the consequence of autosomal
predominant changes in APP, PSEN1 and PSEN2 qualities, situated on chromosome 21, 14,
and 1, separately. Even more explicitly, PSEN1 and PSEN2 contain the vital amino corrosive
deposits needed for the reactant dynamic site of gamma-secretase. Certain transformations of
these qualities lead to expanded creation of Ab peptide and neurodegeneration. Undeniably
more regularly, the genetic danger factor for SAD was recognized as the sort e4 allele on
chromosome 19, of the gene for apolipoprotein E (APOE), a low-thickness lipoprotein
transporter dwell. APOE is available in approximately 50- 60% of patients with AD
contrasted with 20-25% in sound older grown-ups without the historical backdrop of familial
AD.
1.3 TESTING
AD remains a clinical diagnosis and is reliant on a detailed history, cognitive assessment, and
physical exam. Structural imaging is also an important component of the assessment for AD.
Atrophy of the medial temporal lobes on magnetic resonance imaging (MRI) is considered a
diagnostic marker for the mild cognitive impairment stage of AD. Similarly, hypometabolism
in the parieto-temporal association area, posterior cingulate and precuneus on
fluorodeoxyglucose PET imaging is associated with AD.
2. PRELIMINARY DATA COLLECTION
Publication databases are often accessed using the library portals of the schools or by
individually registering on the websites. Several methods are available to retrieve data from
the quality databases like Scopus, Clarivate, Science Direct, Mendeley, Research gate,
Google Scholar etc. Scopus database accessed on 19th September has been considered during
this paper because it is that the largest among the peer reviewed databases. List of the
keywords used is given within the following section.

2.1

Important keywords

The important keywords required to carry the search were “Alzheimer’s”, “Machine
Learning” and “MRI”. The other keywords are enumerated in table 1.
Table 1 List of Keywords
Keywords

Number of Publications

Alzheimer's Disease

126

Machine Learning

106

Magnetic Resonance Imaging

99

Neurodegenerative Diseases

69

Neuroimaging

57

Brain

50

Major Clinical Study

48

Mild Cognitive Impairment

47

Diagnostic Imaging

38

Deep Learning

35

Support Vector Machine

34

Feature Extraction

33

Cognitive Defect

27

Computer Assisted Diagnosis

26

Image Processing

26

Convolutional Neural Network

22

Disease Classification

22

Learning Algorithms

20

The search was further restricted to English publications only. There were 169 English
publications. Table 2. shows the publications of different language.
Table 2 Trends in publishing language
Publication Type

Publication Type

English

169

Chinese

3

Total

172

Researchers have published 70.34% papers in journals, 18.60% papers in conference
proceedings and 11.04% in book series as in table 3.
Table 3 Publication type

2.2

Publication Type

Number of Publication

Percentage from 169

Journal

118

70.34%

Conference Proceeding

32

18.60%

Book Series

19

11.04%

Highlights of preliminary data

In this paper the preliminary investigation is completed supported the keywords that extracted
169 publications from the Scopus database. Documents like journal papers, conference
proceedings and book series were retrieved from 2018 to 2021 for the research area of
Alzheimer’s disease classification. The publication count per annum is as shown in table 4.
Analysis supported number of publications per annum is shown in figure 1.
Table 4 Year wise publication count
Publication Type

Publication Type

2021

3

2020

53

2019

71

2018

42

Total

169

Figure 2 Yearly publishing trends (2018-21)

2.3 Data investigation
Through the conducted bibliometric review reveals about the typography of literatures
available in the next section which will highlight the distinctness of the available literature
and using the geographical dispersion and the contributions by different authors, where the
papers were published and the affiliation statistics.

3. BIBLIOMETRIC ANALYSIS
To perform the bibliometric analysis two ways were used


Geographical region analysis



Statistics of affiliations, subject area, author statistics and document type.

3.1 Geographical region analysis
The geographical regions of attentiveness of the published papers are shown in figure 2
which is drawn using GPS Visualizer tool from gpsvisualizer.com. Indian and Chinese

publications are of the maximum number. Figure 3 shows the contribution in publications by
different countries.

Figure 3 Geographical locations of the study

Figure 4: Analysis by country / Region

3.2 Analysis based on subject area
Categorization based on subject area is shown in figure 4. The analysis reveals that maximum
number of research papers are published from the area of Computer science, Engineering
followed by Medicine, Neuroscience and Mathematics.

Figure 5 Analysis based on Subject area

3.3 Analysis based on affiliation
Contributions by different Universities worldwide in publishing research papers in the field
of classification of Alzheimer’s disease is shown in figure 5. The research area of
classification of Alzheimer’s disease dominated by the Indian and Chinese Universities listed
in figure 5. Top ten Universities publishing in this field have been shown.

Figure 6 Analysis based on Affiliation

3.4 Analysis based on number of publications per author
Key authors contributing to the field of classification of Alzheimer’s disease are depicted in
figure 6. First ten authors were considered from the available accessed data from the Scopus
database.

Figure 7 Analysis based on publication per author

3.5 Journal Statistics
The publication source types are shown in figure 7. It is clear from figure 7 that 29.8%
publications are conference proceedings, 65.5% publications are from journal, 1.2% from
book series and 3.5% are review publications.

Figure 8 Analysis based on document type

3.6 Statistics by document source
Figure 8 shows the statistics for publications in Classification of Alzheimer’s disease. From
the available extracted data, it is apparent that maximum number of publications are from the
Advances in Intelligent systems and computing journal.

Figure 9 Analysis by document source

4. LIMITATIONS OF THIS STUDY
Different combinations of keywords were entered to explore the Scopus database for the
aim of bibliometric review. A couple of important journals and articles which were not
available in Scopus database could not be incorporated during this study.
5. CONCLUSIONS
Great advancement in computer intelligence and deep learning techniques, with the help
of increase in computational power over the years, medical imaging sector has had a huge
positive impact on classification and segmentation of neurodegenerative diseases. With
new computer aided detection techniques for image analysis of MRI’s and EEG’s on the
rise, early detection of neurodegenerative diseases such as Alzheimer’s Disease has
become more accurate and has helped doctors to get hold of the symptoms at an early
stage . Although deep learning methods have a high impact on the quantitative chemical
analysis of brain MRI, there's still difficulty find a strong, generic method. In this paper
we reviewed various studies of brain structure and different classification techniques used
for detection of Alzheimer’s disease for both MRI and EEG, which when used together
along with a deep learning technique can significantly improve diagnostic accuracy.
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